AN EVALUATION OF THE ROLE OF RESPIRATORY SYNCYTIAL VIRUS (RSV), ALONE AND WITH OTHER PATHOGENS, IN CAUSING RESPIRATORY DISEASE AMONG NATIVE AMERICAN CHILDREN

Driscoll, Amanda Jenne

Publication date

October 2018

Publisher

The Busan Gyeongnam Mathematical Society

Abstract

Respiratory syncytial virus (RSV) is associated with 3.2 million severe lower respiratory illness (LRI) episodes and 118,200 deaths in children <5 years of age annually, with the greatest burden in infants less than 6 months of age. There is no licensed vaccine for RSV, although several candidates are in development. It is not well understood how the prevention of RSV LRI in infancy might impact LRI with other pathogens, or long-term sequelae including subsequent wheeze and asthma. Recently, a double-blinded randomized trial of a monoclonal antibody, motavizumab, showed efficacy for the prevention of RSV-associated medically attended LRI (MALRI) in healthy Native American infants. Infants were followed through three years of age, with nasop...

Extracted data

We use cookies to provide a better user experience.

Data Protection

AN EVALUATION OF THE ROLE OF RESPIRATORY SYNCYTIAL VIRUS (RSV), ALONE AND WITH OTHER PATHOGENS, IN CAUSING RESPIRATORY DISEASE AMONG NATIVE AMERICAN CHILDREN

Abstract

Extracted data

AN EVALUATION OF THE ROLE OF RESPIRATORY SYNCYTIAL VIRUS (RSV), ALONE AND WITH OTHER PATHOGENS, IN CAUSING RESPIRATORY DISEASE AMONG NATIVE AMERICAN CHILDREN

Abstract

Extracted data

Related items

Related items